ELF Should I Buy
-
$
0.000
0.000(0.000%)
At close0.000(0.000%)Aft-market
ET
Elf Beauty Inc. (ELF) is not a strong buy at the moment for a long-term beginner investor with $50,000-$100,000 available for investment. While the company has shown strong financial growth and positive catalysts such as the Rhode acquisition, the stock faces headwinds from analyst downgrades, slowing core business growth, and macroeconomic pressures. The technical indicators and options data suggest mixed sentiment, and the stock's recent price trend indicates potential short-term downside. A hold strategy is recommended until clearer positive momentum or valuation support emerges.
The MACD is positive and expanding, indicating bullish momentum. RSI is neutral at 67.927, and moving averages are converging, suggesting indecision. The stock is trading near its resistance level (R1: 69.692), with key support at 64.886. The stock has an 80% chance of declining -1.5% in the next week and -10.53% in the next month, based on candlestick pattern analysis.
Strong financial performance in Q3 2026, with revenue up 37.76% YoY and net income up 128.12% YoY.
The acquisition of Rhode is expected to boost sales growth and expand market presence.
Positive sentiment in the news, highlighting ELF as an undervalued stock with long-term potential.
Analyst downgrades and price target reductions from multiple firms, citing slowing core business growth and macroeconomic pressures.
Slowing consumption trends and potential saturation in the U.S. market.
Mixed sentiment in options data, with a bearish tilt.
In Q3 2026, ELF reported strong growth: revenue increased by 37.76% YoY to $489.5M, net income rose by 128.12% YoY to $39.38M, and EPS grew by 116.67% YoY to $0.65. However, gross margin slightly declined to 70.99%, down 0.42% YoY.
Analysts have mixed views: Citi and BofA maintain Buy ratings with reduced price targets ($87 and $93, respectively). UBS and Deutsche Bank downgraded the stock to Neutral or Hold, citing macroeconomic risks and slowing growth. The average price target has been lowered significantly, reflecting cautious sentiment.
